← Eichor
Study identifier: NCT07295938 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease

Condition: Mycobacterium Abscessus Pulmonary Disease  ·  Sponsor: Shanghai University of Traditional Chinese Medicine

PhasePhase 2
Planned participants352
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Chinese herbs can facilitate sputum culture conversion, promote lesion absorption, and enhance clinical symptoms and quality of life for patients with Mycobacterium abscessus pulmonary disease (MAB-PD). The investigators aimed to evaluate the efficacy of Chinese herbs as adjunct therapy to improve cure rates or reduce recurrence rates during the continuation phase of MAB-PD treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Shaoyan Zhang  ·  +8621-64385700-1307  ·  zhangshaoyan000@163.com

Zhenhui Lu  ·  +8621-64385700-1307  ·  tcmdoctorlu@163.com

Always discuss trial participation with your own doctor first.

Locations (8)

Beijing Chest Hospital Affiliated to Capital Medical UniversityBeijing, ChinaNot Yet Recruiting
China-Japan Friendship HospitalBeijing, ChinaNot Yet Recruiting
Guangzhou Municipal Hospital of Chest MedicineGuangdong, ChinaRecruiting
Anhui Provincial Chest HospitalHefei, ChinaRecruiting
Jiangxi Chest HospitalNanchang, ChinaNot Yet Recruiting
Fudan University Affiliated Huashan HospitalShanghai, ChinaNot Yet Recruiting
Longhua Hospital Affiliated Shanghai University of TCMShanghai, ChinaRecruiting
Shanghai Pulmonary HospitalShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07295938